McKesson (MCK) is scheduled to announce Q2 earnings results on Wednesday, November 5th, after market close. The consensus EPS ...

McKesson's Q2 results may show steadier growth as strong U.S. pharmaceutical and RxTS momentum drive its expanding top line.

McKesson is expected to announce its second-quarter results next month, and analysts predict a double-digit increase in the ...

McKesson (MCK) declares $0.82/share quarterly dividend, in line with previous. Forward yield 0.41% Payable Jan. 2; for ...

San Francisco-based McKesson Corp., a retail pharmaceutical distributor that also provides health information technology, medical supplies, and care management tools, recently opened a new campus in ...

McKesson Corp has appointed Tracy Faber to executive vice president and chief human resources officer, which will take effect in October. She will report to McKesson’s new CEO Brian Tyler. Faber has ...

IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its first quarter fiscal 2025 financial results after market close on Wednesday, August 7, 2024. The company will host a ...

McKesson Corporation (NYSE:MCK) is one of the 11 Best Drug Stocks to Buy According to Hedge Funds. On June 11, analyst Michael Cherny of Leerink Partners maintained a Buy rating on McKesson ...

McKesson Corporation is a large player in the medical space, with a market capitalization of $75.86 billion. The company has shown attractive top-line growth, but bottom-line results have been ...

McKesson Corp. closed 3.08% below its 52-week high of $846.32, which the company reached on October 30th.

Count yourself lucky if you were a McKesson Corporation (NYSE: MCK) investor this year. While most of the stocks have fallen steeply, McKesson has grown more than 10%, increasing from $139 to $153 (as ...

New York state prosecutors have served the McKesson Corp. with a subpoena in connection with a multistate investigation into the San Francisco-based drug distribution giant’s opioid marketing and ...